Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Currency
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
RESEARCH TOOLSreports
Vincerx Pharma Inc (VINC) Stock Price & Analysis
96 Followers
VINC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.63 - $1.95
Previous Close$0.63
Volume137.04K
Average Volume (3M)49.26K
Market Cap
$14.11M
Enterprise Value-$3.93M
Total Cash (Recent Filing)$20.80M
Total Debt (Recent Filing)$2.77M
Price to Earnings (P/E)-0.3
Beta0.91
Next Earnings
Mar 26, 2024EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.30
Shares Outstanding21,380,570
10 Day Avg. Volume80,617
30 Day Avg. Volume49,263
Standard Deviation0.24
R-Squared0.00111
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.90
Price to Sales (P/S)45.04
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit-13.09
Enterprise Value/Ebitda0.10
Forecast
1Y Price Target
$4.00Price Target Upside515.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Vincerx Pharma Inc News
Ownership Overview
0.00% Insiders
3.00% Mutual Funds
25.51% Other Institutional Investors
71.49% Public Companies and
Individual Investors
VINC FAQ
What was Vincerx Pharma Inc’s price range in the past 12 months?
Vincerx Pharma Inc lowest stock price was $0.63 and its highest was $1.95 in the past 12 months.
What is Vincerx Pharma Inc’s market cap?
Currently, no data Available
When is Vincerx Pharma Inc’s upcoming earnings report date?
Vincerx Pharma Inc’s upcoming earnings report date is Mar 26, 2024 which is in 106 days.
How were Vincerx Pharma Inc’s earnings last quarter?
Vincerx Pharma Inc released its earnings results on Nov 14, 2023. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.457 by -$0.003.
Is Vincerx Pharma Inc overvalued?
According to Wall Street analysts Vincerx Pharma Inc’s price is currently Undervalued.
Does Vincerx Pharma Inc pay dividends?
Vincerx Pharma Inc does not currently pay dividends.
What is Vincerx Pharma Inc’s EPS estimate?
Vincerx Pharma Inc’s EPS estimate is -$0.37.
How many shares outstanding does Vincerx Pharma Inc have?
Vincerx Pharma Inc has 21,380,570 shares outstanding.
What happened to Vincerx Pharma Inc’s price movement after its last earnings report?
Vincerx Pharma Inc reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.457. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of Vincerx Pharma Inc?
Among the largest hedge funds holding Vincerx Pharma Inc’s share is Baker Bros Advisors LP. It holds Vincerx Pharma Inc’s shares valued at N/A.
---
Vincerx Pharma Inc Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (515.38% Upside)
$4.00 (515.38% Upside)
Hedge Fund Trend
Decreased
By 225.6K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.05%
12-Months-Change
Fundamentals
Return on Equity
-129.49%
Trailing 12-Months
Asset Growth
-63.70%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vincerx Pharma Inc
LifeSci Acquisition Corp is a blank check company.
---
Top 5 ETFs holding VINC
Vanguard Total Stock Market ETF
$308.92K
Up to five ETFs with an Outperform Smart Score that hold VINC. The ETFs are listed according to market value of VINC within the ETF
---